CoChat

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; none of the 63 sources its claims cite is checked for support yet.

Dysfunctional conformational dynamics of protein kinase A induced by a lethal mutant of phospholamban hinder phosphorylation

Open access

Abstract

Significance: In the heart, phospholamban regulates Ca 2+ -ATPase function, controlling cardiac output. A single deletion (R14del) in the phospholamban recognition sequence kinase A is linked to the progression of familial dilated cardiomyopathy, a leading cause of death worldwide. Here, we provide the molecular mechanism for the sluggish phosphorylation of R14del by protein kinase A. We found that the R14 deletion affects the organization of the active site, which remains partially open and quite dynamic, preventing the formation of catalytically committed complex. We conclude that well-tuned structural and dynamic interplay between kinase and substrate is crucial for efficient phosphorylation. These results provide new structural basis to understand for the reduced phosphorylation levels of the R14del phospholamban and impaired Ca 2+ transport in heart muscle.

Overview

CoChat Summary

TL;DR

The R14del phospholamban mutant binds PKA-C weakly and fails to drive the kinase into a catalytically committed closed conformation, producing dysfunctional conformational dynamics and sluggish phosphorylation. These findings provide a molecular mechanism linking R14del to impaired Ca²⁺ handling in dilated cardiomyopathy.

Key findings

  • R14del reduces PKA-C binding affinity: WT PLN peptide binds with Kd = 28 μM, whereas the R14del peptide binds with Kd ∼ 200 μM; the entropic contribution changes from TΔS = −0.37 kcal/mol for WT to TΔS ∼ 4 kcal/mol for the mutant.
  • Phosphorylation is severely impaired: WT peptide behaves similarly to Kemptide (kcat = 23 ± 1 s⁻¹), while R14del shows no significant phosphorylation under the same conditions; under increased enzyme/substrate conditions, R14del has kcat ∼6 times smaller and catalytic efficiency ∼300 times lower than WT. Full-length WT PLN is completely phosphorylated (five phosphates per pentamer), whereas full-length R14del is only partially phosphorylated.
  • NMR shows R14del fails to shift PKA-C toward the closed, catalytically committed state; the mutant complex remains in an intermediate/partially closed state with enhanced microsecond/millisecond dynamics in catalytic regions, including the glycine-rich loop, Mg²⁺-positioning loop, APE motif, acidic patch, and D220.
  • MD simulations indicate that loss of the P-3 arginine disrupts the R13-mediated bridge between the small lobe, large lobe, and ATP; the R14del complex samples conformations closer to the open/intermediate basin, with increased dynamics in the glycine-rich, αF-αG, and αG-αH loops and increased rigidity in the αA-β1 linker and C terminus.

Methods

  • The study combined steady-state phosphorylation kinetics, isothermal titration calorimetry (ITC), solution NMR spectroscopy, dynamic light scattering, and atomistic molecular dynamics (MD) simulations to compare PKA-C complexes with WT versus R14del PLN peptides (first 19 residues) and full-length PLN.
  • ITC measured binding thermodynamics in the presence and absence of ATPγN; kinetics used a coupled enzyme assay and gel-shift assays for full-length PLN; NMR experiments at 850 MHz included TROSY triple-resonance assignment, [¹H,¹⁵N]-TROSY-HSQC chemical shift mapping, CONCISE analysis, heteronuclear steady-state NOE (HX-NOE), and TROSY Hahn-Echo Rex measurements.
  • MD simulations started from the PKA-C crystal structure (PDB ID 3O7L) with HADDOCK-docked substrates in explicit solvent; the Methods state 80 ns simulations, while the text refers to ∼100 ns simulations, followed by principal component analysis (PCA) and root mean square fluctuation (RMSF) analysis.

Limitations

  • The paper does not state a dedicated limitations section. Evident from the text: the mechanistic conclusions rely on in vitro reconstituted systems using purified PKA-C and synthetic peptides or full-length PLN, with no cellular or in vivo validation reported.
  • Evident from the text: MD simulations are relatively short (80 ns in Methods; text mentions ∼100 ns) and begin from docked structures, so they may not capture all slower conformational motions relevant to catalysis.
  • Evident from the text: full-length PLN phosphorylation was assessed by gel-shift assays rather than detailed kinetics, and the NMR/ITC studies primarily use truncated peptides, which may not fully replicate the membrane environment of full-length PLN.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1073/pnas.1502299112

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 0 Not valid · 38 Not checked · 45 Own results and interpretations

33 more claims

Create a free account to see all 83 claims and to verify the 63 references still open.

See all claims — free account
  • It may state two separate claims as one. 39
  • The quote only partly states this claim. 2
  • Probably not a substantial claim. 11

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

11 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 56 references

Cited by

Metadata

Authors
Kim, J., Masterson, L. R., Cembran, A., Verardi, R., Shi, L., Gao, J., Taylor, S. S., & Veglia, G.
Affiliations
  • Departments of aChemistry and
  • University of Minnesota (US)
  • Jilin University (CN)
  • Howard Hughes Medical Institute (US)
Venue
Proceedings of the National Academy of Sciences
Published
2015-03-09
Volume
112
Issue
12
Pages
3716-3721
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2127992862
Cited by
45
References
56
Citations by year
2025: 1 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 1 · 2019: 3 · 2018: 9 · 2017: 10 · 2016: 4 · 2015: 6
FWCI
2.75
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • HHS | NIH | National Institute of General Medical Sciences (GM72701, GM46367)
  • HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR007612)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
protein kinase A, phospholamban, familial dilated cardiomyopathy, kinase-substrate interactions, conformational dynamics, catalytic efficiency, phosphorylation kinetics, substrate affinity, cAMP signaling, cardiac contractility, calcium signaling
MeSH terms
Phospholamban, Calcium-Transporting ATPases, Allosteric Site, Amino Acid Sequence, Calcium, Calcium-Binding Proteins, Cardiomyopathy, Dilated, Humans, Ligands, Molecular Sequence Data, Mutation, Myocardium, Magnetic Resonance Spectroscopy, Phosphorylation, Protein Binding, Protein Conformation, Thermodynamics, Gene Deletion, Sequence Homology, Amino Acid, Cyclic AMP-Dependent Protein Kinases, Disease Progression, Catalytic Domain, Molecular Dynamics Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.